A new study finds that ursodeoxycholic acid (UDCA) effectively dissolves gallstones in 60% of patients after sleeve ...

Bradley Monk shares key insights and breakthroughs in gynaecologic oncology from ESGO 2025, shaping cancer care's future.

ATOPIC dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts patients’ quality of life. It is ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

A major meta-analysis of 1.3 million patients confirms remdesivir improves COVID-19 survival. But are treatment guidelines keeping up with the evidence?

Experts stress the need for diversity in basic and clinical research, highlighting recruitment challenges, mentorship gaps, ...

A recent study reveals that nearly half of family surrogate decision-makers for stroke patients face substantial financial ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

A LARGE cohort study of 221,054 US adults has revealed that higher butter intake is associated with increased mortality, ...

Preliminary results from the MITO 40 study presented at ESGO 2025 suggest Niraparib as a promising maintenance treatment for ...

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.